Abstract
Sialic acids (or ulosonic acids) are a family of acidic ketoses (including neuraminic acid, KDN and KDO) that are found at the non-reducing terminus of many glycoconjugates. These saccharide residues are recognized ligands of protein lectins and are removed in the first step in glycoconjugate catabolism. Moreover, sialic acid containing carbohydrates, such as glycolipid gangliosides (i.e. GM3), glycopeptides (i.e. Tn) and polysaccharides (i.e. polysialic acid or colominic acid) play important biological roles. Thus, they represent important targets in natural product synthesis. This review examines the application of sialic acids as donors in glycosylation reactions. The synthesis of protected sialic acid donors and challenges associated with their use in the synthesis of heteronuclear and carbon glycosides are discussed.
Keywords: Sialic Acid, glycoconjugate, carbohydrates, polysialic, colominic
Current Organic Synthesis
Title: Sialic Acid Donors: Chemical Synthesis and Glycosylation
Volume: 1 Issue: 1
Author(s): Dino K. Ress and Robert J. Linhardt
Affiliation:
Keywords: Sialic Acid, glycoconjugate, carbohydrates, polysialic, colominic
Abstract: Sialic acids (or ulosonic acids) are a family of acidic ketoses (including neuraminic acid, KDN and KDO) that are found at the non-reducing terminus of many glycoconjugates. These saccharide residues are recognized ligands of protein lectins and are removed in the first step in glycoconjugate catabolism. Moreover, sialic acid containing carbohydrates, such as glycolipid gangliosides (i.e. GM3), glycopeptides (i.e. Tn) and polysaccharides (i.e. polysialic acid or colominic acid) play important biological roles. Thus, they represent important targets in natural product synthesis. This review examines the application of sialic acids as donors in glycosylation reactions. The synthesis of protected sialic acid donors and challenges associated with their use in the synthesis of heteronuclear and carbon glycosides are discussed.
Export Options
About this article
Cite this article as:
Ress K. Dino and Linhardt J. Robert, Sialic Acid Donors: Chemical Synthesis and Glycosylation, Current Organic Synthesis 2004; 1 (1) . https://dx.doi.org/10.2174/1570179043485448
DOI https://dx.doi.org/10.2174/1570179043485448 |
Print ISSN 1570-1794 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6271 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Mitochondrial Permeability Transition as Target of Anticancer Drugs
Current Pharmaceutical Design Urokinase-a Very Popular Cardiovascular Agent
Recent Patents on Cardiovascular Drug Discovery Writers and Erasers of Histone Lysine methylation with Clinically Applied Modulators: Promising Target for Cancer Therapy
Current Pharmaceutical Design Nano-Based Therapy for Treatment of Skin Cancer
Recent Patents on Anti-Infective Drug Discovery MDA-7/IL-24-Based Cancer Gene Therapy: Translation from the Laboratory to the Clinic
Current Gene Therapy Current Trends in the Use of Cationic Polymer Assemblies for siRNA and Plasmid DNA Delivery
Pharmaceutical Nanotechnology Genetic Modification of Natural Killer Cells for Leukemia Therapies
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Production of Retroviral Vectors: Review
Current Gene Therapy Tumor Targeting Using Radiolabeled Antibodies for Image-Guided Drug Delivery
Current Drug Targets Role of Resveratrol in Modulating microRNAs in Human Diseases: From Cancer to Inflammatory Disorder
Current Medicinal Chemistry Anticancer Activity and Anti-inflammatory Studies of 5-Aryl-1,4-benzodiazepine Derivatives
Anti-Cancer Agents in Medicinal Chemistry Inhibiting Cyclin-Dependent Kinase / Cyclin Activity for the Treatment of Cancer and Cardiovascular Disease
Current Pharmaceutical Biotechnology Highlights in Peptide Nanoparticle Carriers Intended to Oral Diseases
Current Topics in Medicinal Chemistry Targeting Bcl-2 in CLL
Current Medicinal Chemistry A Mechanistic Study on Altered Pharmacokinetics of Irinotecan by St. Johns Wort
Current Drug Metabolism Preparation, Characterization and in vivo Evaluation of Raloxifene Hydrochloride Solid Lipid Nanoparticles
Pharmaceutical Nanotechnology Adipocytes Contribute to Resistance of Human Melanoma Cells to Chemotherapy and Targeted Therapy
Current Medicinal Chemistry CDK Inhibitors: From the Bench to Clinical Trials
Current Drug Targets Cancer-Targeted Oncolytic Adenoviruses for Modulation of the Immune System
Current Cancer Drug Targets Role of Reactive Oxygen Species in Tumor Necrosis Factor-alpha Induced Endothelial Dysfunction
Current Hypertension Reviews